A detailed history of Bender Robert & Associates transactions in Eli Lilly & CO stock. As of the latest transaction made, Bender Robert & Associates holds 18,051 shares of LLY stock, worth $13.9 Million. This represents 3.4% of its overall portfolio holdings.

Number of Shares
18,051
Previous 18,209 0.87%
Holding current value
$13.9 Million
Previous $16.5 Million 3.0%
% of portfolio
3.4%
Previous 3.62%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$772.14 - $960.02 $13.9 Million - $17.3 Million
18,051 New
18,051 $16 Million
Q1 2024

Apr 22, 2024

SELL
$592.2 - $792.28 $229,181 - $306,612
-387 Reduced 1.95%
19,426 $15.1 Million
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $11,554 - $13,620
22 Added 0.11%
19,813 $11.5 Million
Q3 2023

Oct 13, 2023

BUY
$434.7 - $599.3 $13,041 - $17,979
30 Added 0.15%
19,791 $10.6 Million
Q2 2023

Jul 13, 2023

BUY
$350.74 - $468.98 $3.02 Million - $4.04 Million
8,611 Added 77.23%
19,761 $9.27 Million
Q1 2023

Apr 20, 2023

BUY
$310.63 - $364.82 $36,033 - $42,319
116 Added 1.05%
11,150 $3.83 Million
Q4 2022

Feb 02, 2023

BUY
$321.55 - $374.67 $24,116 - $28,100
75 Added 0.68%
11,034 $4.04 Million
Q3 2022

Oct 26, 2022

BUY
$296.48 - $337.87 $219,395 - $250,023
740 Added 7.24%
10,959 $3.54 Million
Q2 2022

Jul 19, 2022

BUY
$278.73 - $327.27 $54,352 - $63,817
195 Added 1.95%
10,219 $3.31 Million
Q1 2022

Apr 14, 2022

BUY
$234.69 - $291.66 $229,996 - $285,826
980 Added 10.84%
10,024 $2.87 Million
Q3 2021

Nov 09, 2021

BUY
$221.6 - $272.71 $1.06 Million - $1.3 Million
4,783 Added 112.25%
9,044 $2.09 Million
Q3 2021

Nov 03, 2021

SELL
$221.6 - $272.71 $1.06 Million - $1.3 Million
-4,778 Reduced 52.86%
4,261 $697,000
Q2 2021

Jul 16, 2021

BUY
$180.55 - $233.54 $171,883 - $222,330
952 Added 11.77%
9,039 $2.08 Million
Q1 2021

Apr 28, 2021

BUY
$164.32 - $212.72 $121,103 - $156,774
737 Added 10.03%
8,087 $1.51 Million
Q4 2020

Jan 29, 2021

BUY
$130.46 - $172.63 $111,543 - $147,598
855 Added 13.16%
7,350 $1.24 Million
Q3 2020

Oct 29, 2020

BUY
$146.22 - $169.13 $29,244 - $33,826
200 Added 3.18%
6,495 $961,000
Q2 2020

Jul 31, 2020

BUY
$136.42 - $164.18 $114,592 - $137,911
840 Added 15.4%
6,295 $1.03 Million
Q4 2019

Jan 31, 2020

SELL
$106.92 - $132.43 $12,081 - $14,964
-113 Reduced 2.03%
5,455 $717,000
Q2 2019

Jul 30, 2019

SELL
$110.79 - $129.32 $13,848 - $16,165
-125 Reduced 2.2%
5,568 $603,000
Q1 2019

Apr 30, 2019

BUY
$111.31 - $131.02 $13,913 - $16,377
125 Added 2.24%
5,693 $739,000
Q4 2018

Jan 24, 2019

BUY
$105.9 - $118.64 $2,647 - $2,966
25 Added 0.45%
5,568 $644,000
Q3 2018

Oct 17, 2018

SELL
$85.86 - $107.31 $13,737 - $17,169
-160 Reduced 2.81%
5,543 $595,000
Q2 2018

Jul 27, 2018

SELL
$75.7 - $86.88 $8,327 - $9,556
-110 Reduced 1.89%
5,703 $487,000
Q1 2018

Apr 27, 2018

SELL
$74.21 - $87.6 $8,163 - $9,636
-110 Reduced 1.86%
5,813 $450,000
Q4 2017

Jan 19, 2018

SELL
$81.94 - $87.89 $11,471 - $12,304
-140 Reduced 2.31%
5,923 $500,000
Q3 2017

Oct 23, 2017

BUY
$77.07 - $85.54 $467,275 - $518,629
6,063
6,063 $519,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bender Robert & Associates Portfolio

Follow Bender Robert & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Bender Robert & Associates with notifications on news.